TS
TTRX

Tamar Securities’s Turn Therapeutics TTRX Stock Holding History

Tamar Securities’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96K Buy
30,000
+15,000
+100% +$58.5K 0.01% 80
2025
Q4 		$59.1K Buy
+15,000
New +$62.5K 0.01% 87

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $464M AUM 16.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $7.29B AUM 16.22% 1-Year Est. Return

Tamar Securities's TTRX Position: Q1 2026 in Review

Tamar Securities increased its Turn Therapeutics (TTRX) stake by 100% in Q1 2026, buying an estimated $58.5K and bringing the position to 30,000 shares worth $96K. The position accounts for 0.01% of the portfolio, ranked #80.

Tamar Securities first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • Tamar Securities held 30,000 shares of Turn Therapeutics worth $96K as of Q1 2026.
  • Tamar Securities bought 15,000 Turn Therapeutics shares in Q1 2026, an estimated $58.5K.
  • Turn Therapeutics made up 0.01% of Tamar Securities's portfolio in Q1 2026, its #80 holding.
  • Tamar Securities first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on Tamar Securities's 13F filing for Q1 2026, filed 14 May 2026.